Project Grant HT9425261E014
Award Date 6/1/26
Completion Date 5/31/29
Dollars Obligated $1.1M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Irwindale, CA 91010, USA
Similar Awards
- Federal Project Grant Summary The Beckman Research Institute of the City of Hope received a $5.34 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) awarded on June 15, 2025, with a completion date of June 14, 2029. The award funds development of a digital health intervention platform designed to enable self-management and telemonitoring capabilities for patients undergoing Chimeric Antigen Receptor T-Cell...
- Federal Grant Award Summary Beckman Research Institute of the City of Hope received a $2.136 million Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the period September 1, 2025 through August 31, 2028. The award supports developmental therapeutics research and the investigation of potential treatment strategies targeting RALBP1 (Retinoid-binding Protein 1) for castration-resistant prostate carcinoma. This...
- Federal Project Grant Award Summary The Beckman Research Institute of the City of Hope received a $1.32M Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective September 15, 2025, with completion targeted for September 14, 2029. The award supports research titled "Targeting Diabetes-Associated Radioresistance to Improve Prostate Cancer Control and Quality-of-Life Outcomes," conducted at the...
- This Project Grant award of $1,759,998.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by the Beckman Research Institute of the City of Hope to potentiate T cell activity against multiple myeloma through inhibition of sumoylation. The research aims to transform healthcare for Service Members and the American public through innovative and impactful work. The award term runs from Aug 1, 2023 to Jul 31, 2026. As a...
- Federal Project Grant Award Summary The Beckman Research Institute of the City of Hope received a $177,992 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period September 1, 2025 through August 31, 2027. The award supports the generation of novel tools and development of targeted approaches for AL (light chain) amyloidosis, a rare protein misfolding disorder affecting multiple organ systems. The research will...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded The Institute For Cancer Research a $1,959,353 project grant effective September 1, 2025 through August 31, 2029, under the Military Medical Research and Development program (CFDA 12.420). This award supports clinical research investigating pembrolizumab maintenance therapy following enfortumab vedotin/pembrolizumab induction treatment in front-line metastatic urothelial carcinoma. The research will be conducted at the...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded Sloan-Kettering Institute For Cancer Research a $533,308 Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2029. The award funds research titled "Integrated Immunomodulatory Analysis of LAG3 Inhibition in Renal Cell Carcinoma," which investigates lymphocyte-activation gene 3 (LAG3) checkpoint inhibition as a therapeutic...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded $352,000 under the Military Medical Research and Development program (CFDA 12.420) to the Sloan-Kettering Institute for Cancer Research for the project period September 1, 2025, through August 31, 2027. The award supports research focused on augmenting the in vivo efficacy of a novel lanosterol synthase inhibitor in glioblastoma treatment. This research aligns with the DHA's mission to transform healthcare for service...
- Federal Grant Award Summary Dana-Farber Cancer Institute, Inc. (DFCI) received a $1.424 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded August 1, 2025, with a performance period through July 31, 2029. The award supports research to expand the targetable tumor antigen repertoire of renal cell carcinoma, positioning the work within DHA's broader portfolio of hypothesis-driven biomedical research...
- Federal Grant Award Summary The Defense Health Agency awarded Sloan-Kettering Institute for Cancer Research $1,108,654 under the Military Medical Research and Development program (CFDA 12.420) on September 30, 2025, for a four-year project titled "Accelerating Global Research for Relapsed or Refractory Extracranial Malignant Germ Cell Tumors" (completion date: September 29, 2029). The project delivers research and development services focused on advancing clinical care and...